1875 — BioDlink International Co Balance Sheet
0.000.00%
- HK$3.86bn
- HK$3.93bn
- CNY747.65m
Annual balance sheet for BioDlink International Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 153 | 458 | 352 | 381 | 328 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 27 | 62.7 | 143 | 193 | 100 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 306 | 677 | 693 | 743 | 561 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 379 | 563 | 712 | 738 | 682 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 710 | 1,262 | 1,426 | 1,509 | 1,259 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 261 | 275 | 382 | 415 | 274 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 375 | 548 | 739 | 779 | 633 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 335 | 714 | 687 | 730 | 626 |
| Total Liabilities & Shareholders' Equity | 710 | 1,262 | 1,426 | 1,509 | 1,259 |
| Total Common Shares Outstanding |